Italy· 043034014
NOVOTHIRTEEN*1 flaconcino EV 2.500 Unita' Internazionali + 1 flaconcino 3,2 ml
A catridecacog product containing catridecacog, registered in Italy by NOVO NORDISK A/S, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Catridecacog is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD11 (catridecacog), each read from that country’s own register.
- This record: Italy
- 7 of them publish a price we can compare per daily dose
Catridecacog · ATC B02BD11
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
- Active substance
- Catridecacog
- Manufacturer
- NOVO NORDISK A/S
- Country
- Italy (IT)
- ATC code
- B02BD11
- ATC class
- Catridecacog
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043034014NOVOTHIRTEEN*1 flaconcino EV 2.500 Unita' Internazionali + 1 flaconcino 3,2 mlEUR 33274.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Catridecacog in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNovoThirteen 2,500unit powder and solvent for solution for injection vialsNovo Nordisk Ltd
- CanadaTRETTENNOVO NORDISK CANADA INC
- CzechiaNOVOTHIRTEENNovo Nordisk A/S, Bagsvaerd
- SpainNOVOTHIRTEEN 2500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- FinlandNovothirteenNovo Nordisk A/S
- IcelandNovoThirteenNovo Nordisk A/S
- Japanカトリデカコグ（遺伝子組換え）ノボ ノルディスク ファーマ
- NetherlandsNovoThirteen, poeder en oplosmiddel voor oplossing voor injectieNovo Nordisk A.S.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Novothirteen
- Norway · Novothirteen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db8421aa-b09a-4ccb-991f-2a1dda901619 GET /v1/drugs/db8421aa-b09a-4ccb-991f-2a1dda901619?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 33274.19,
"source": "aifa",
"currency": "EUR",
"strength": "CATRIDECACOG (FATTORE XIII DI COAGULAZIONE, RICOMBINANTE) 2.500UI 3,2ML 1 UNITA' USO PARENTERALE",
"substance": "Catridecacog",
"equivalence_group": "CAK",
"transparency_flag": null
}See everything about catridecacog.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.